Seizure relapse in new onset epilepsy: It is not always drug resistance
Epilepsia · 2026
DOI: 10.1002/epi.70298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Cecilia Catania und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, EEG & Epilepsy Unit, University Hospitals of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures, Drug Resistant Epilepsy, Epilepsy. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Objective
Seizure recurrence in new onset epilepsy (NOE) can result from various factors. Although drug ineffectiveness is frequently investigated, other causes—such as nonadherence, inadequate treatment, nonepileptic events (e.g., functional/dissociative), or acute symptomatic seizures—also impact patient outcomes. This retrospective, longitudinal single‐center study evaluated relapse causes over a 5‐year period in a cohort of NOE patients.
Methods
We reviewed the NOE registry of Geneva University Hospital, including adult patients diagnosed between 2005 and 2019. Of 740 consecutive patients, 330 with more than 5 years of follow‐up were included in the analysis. Relapses after antiseizure medication (ASM) initiation were classified into seven categories: poor adherence, inadequate treatment, ineffective treatment, acute symptomatic seizures, nonepileptic seizures, multiple, and unknown causes. Mixed‐effects logistic regression and post hoc analyses were used to assess temporal trends.
Results
A total of 202 of 330 patients (61%) experienced at least one relapse; 181 occurred after ASM initiation. Of these, 32% (57/181) were due to treatment ineffectiveness, whereas 68% were attributable to other causes. Inadequate treatment was the most frequent cause in year 1 (37%) but declined to 10% by year 5 ( p < .001). Poor adherence remained stable (27%–38%). The proportion of drug ineffectiveness as a cause of relapse increased over time (22% in year 1 to 41% in year 5). Drug‐resistant epilepsy (DRE) was diagnosed in 7% of the entire cohort. Generalized tonic–clonic (GTC) seizures at relapse were associated with poor adherence, whereas non‐GTC seizures were linked to ineffectiveness ( p < .001). Significance In our cohort, most early relapses in NOE were due to modifiable factors. Systematic identification of relapse causes can prevent misclassification of DRE and reduce unnecessary treatment escalation. The high proportion of patients lost to follow‐up is a relevant limitation of this study; however, a substantial selection bias is unlikely.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, EEG & Epilepsy Unit, University Hospitals of Geneva, Geneva, Switzerland.
- Diagnostic and Interventional Neuroradiology Unit, Berne, Switzerland.
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
- Emergency Department, University Hospitals of Geneva, Geneva, Switzerland.
- Diagnostic and Interventional Neuroradiology, University Hospital, Berne, Switzerland.
- Department of Clinical Neurophysiology, Copenhagen University Hospital, Copenhagen, Denmark.
ORCID-Profile: Cecilia Catania, Aikaterini Fitsiori, Gabriela Moreno Legast, Sandor Beniczky
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Catania, C., Menetre, E., Fitsiori, A., Kurz, F. T., Moreno Legast, G., Vulliemoz, S., Genoud, M., Mégevand, P., Wiest, R., Picard, F., Beniczky, S., & Seeck, M. (2026). Seizure relapse in new onset epilepsy: It is not always drug resistance. Epilepsia. https://doi.org/10.1002/epi.70298
Vancouver
Catania C, Menetre E, Fitsiori A, Kurz FT, Moreno Legast G, Vulliemoz S, et al. Seizure relapse in new onset epilepsy: It is not always drug resistance. Epilepsia. 2026. doi:10.1002/epi.70298
BibTeX
@article{Catania2026,
author = {Catania, Cecilia and Menetre, Eric and Fitsiori, Aikaterini and Kurz, Felix Tobias and Moreno Legast, Gabriela and Vulliemoz, Serge and Genoud, Mathieu and Mégevand, Pierre and Wiest, Roland and Picard, Fabienne and Beniczky, Sandor and Seeck, Margitta},
title = {Seizure relapse in new onset epilepsy: It is not always drug resistance},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70298}
}
EUVIMED